Use of Cholesterol-Lowering Drugs May Reduce Cancer Risk

According to Wildon Farwell, M.D., of the Veterans Affairs Boston Healthcare System and colleagues, patients that are on cholesterol-lowering drugs – statins – may be at a lower risk for developing...

Participants to Advanced Liver Cancer Study, Wanted by Moffitt

The Moffitt Cancer Center in Tampa, Florida is seeking patients who have primary liver cancer (hepatocellular carcinoma) that has spread to other organs or is too advanced to be treated by surgery...

Short-Term Hormone Therapy Can Delay Prostate Cancer Growth By Up To 8 Years

Just four months of hormonal (androgen deprivation) therapy before and with standard external beam radiation therapy slowed cancer growth by as much as eight years–especially the development of...

More Good News From Gleevec

The targeted cancer pill – Gleevec - has been approved for the treatment of gastrointestinal stromal tumors, pediatric CML, as well as five additional rare cancers. While it has been reported to have...

WBZ-4: Re-engineered Gleevec™, Reduces Cardio Risks

The powerful anti-cancer drug imatinib (Gleevec™) has been re-engineered by researchers at Rice University and the University of Texas M. D. Anderson Cancer Center. Developed by Novartis...